1008 - Regulatory Affairs, Quality Systems, Policy, and Ethics: AUTOLOGOUS CAR T CELL PRODUCT FROM COVID-19-POSITIVE PATIENT: MANUFACTURING AND REGULATORY CONSIDERATIONS
Autor: | Sikder, D., Senechal, B., Wang, X., Geyer, M., Riviere, I. |
---|---|
Zdroj: | In Cytotherapy May 2022 24(5) Supplement:S191-S191 |
Databáze: | ScienceDirect |
Externí odkaz: |